The effect of L-carnitine on wound healing by secondary intention in an animal model

Wounds

Volumn 17, Issue 3, 2005, Pages 62-66

  Koybasi, Serap ^a   Yilmaz, Taner ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; SODIUM CHLORIDE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INSTRUMENTATION; NONHUMAN; RAT; REACTION TIME; SKIN DEFECT; STATISTICAL SIGNIFICANCE; THICKNESS; WOUND HEALING;

EID: 17444385966     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cotran RS, Kumar V, Collins T, Robbins SL. Tissue repair: cellular growth, fibrosis and wound healing. In: Robbins Pathologic Basis of Disease. 6th ed. Philadelphia, PA: WB Saunders Company, 1999:89-112.
2. Murray RK, Granner DK, Mayes P, Rodwell VW. Harpers Biochemistry. 25th ed. New York, NY: McGraw-Hill, 2000:239.
3. Wyss V, Ganzit GP, Rienzi A. Effects of L-carnitine administration on VO2max and the aerobic-anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol. 1990;60(1):1-6.
4. Hülsmann WC, Dubelaar M-L. Carnitine in metabolism of paced cardiac and skeletal muscles: prevention of acidosis and improvement of vascular flow. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and its Role in Medicine: From Function to Therapy. London, UK: Academic Press, 1992:345-358.
5. Brevetti G, Angelini C, Rosa M, et al. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation. 1991;84(4):1490-1495.
6. Arsenian MA. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis. 1997;40(3):265-286.
7. McCarty MF, Rubin EJ. Rationales for micronutrient supplementation in diabetes. Med Hypotheses. 1984;13(2):139-151.
8. De Grandis D, Minardi C. Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study. Drugs R D. 2002;3(4):223-231.
9. Persico G, Amato B, Aprea G, et al. The early effects of intravenous L-propionyl carnitine on ulcerative trophic lesions of the lower limbs in arteriopathic patients: a controlled randomized study. Drugs Exp Clin Res. 1995;21(5):187-198.
10. Savica V, Calvani M, Benatti P, et al. Carnitine system in uremic patients: molecular and clinical aspects. Semin Nephrol. 2004;24(5):464-468.
11. Ohtani Y, Ohyanagi K, Yamamoto S, Matsuda I. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency. J Pediatr. 1988;112(3):409-414.
12. Stumpf DA, Parker WD Jr, Angelini C. Carnitine deficiency, organic acidemias, and Reye's syndrome. Neurology. 1985,35(7):1041-1045.
13. Tellioglu AT, Uras KA, Yilmaz T, Alagozlu H, Tekdemir I, Karabag O. The effect of carnitine on random-pattern flap survival in rats. Plast Reconstr Surg. 2001;108(4):959-962.
14. Pepine CJ. The therapeutic potential of carnitine in cardiovascular disorders. Clin Ther 1991;13(1):2-21.
15. Brevetti G, Perna S. Metabolic and clinical effects of L-carnitine in peripheral vascular disease. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and its Role in Medicine: From Function to Therapy. London, UK: Academic Press, 1992:359-378.
16. Corsi C, Pollastri M, Marrapodi E, et al. L-propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease. Angiology. 1995;46(8):705-713.
17. Pola P, De Martini D, Gerardino L, et al. The action of propionyl-L-carnitine on the vasal endothelium: increased t-PA synthesis and a decrease in the activity of PAI-1. A preliminary study. Drugs Exp Clin Res. 1992;18(3):343-348.
18. Brevetti G, Attisano T, Perna S, et al. Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study. Angiology. 1989;40(10):857-862.
19. Bolognesi M, Amodio P, Merkel C, et al. Effect of 8-day therapy with propionyl-L-carnitine on muscular and subcutaneous blood flow of the lower limbs in patients with peripheral arterial disease. Clin Physiol. 1995;15(5):417-423.
20. Cevese A, Schena F, Poltronieri R, Cerutti G. Short term effects of intra-arterial propionyl-L-carnitine on isolated canine hind-limbs. Cardioscience. 1995;6(1):59-64.
21. Spagnoli LG, Palmieri G, Mauriello A, et al. Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle. Nephron. 1990;55(1):16-23.